drugset
drugset / Trial / NCT05787873

A Clinical Trial to Evaluate the Pharmacokinetics and Safety of SIPS-2209-1 in Healthy Korean Volunteers

NCT05787873 ↗

Phase 1 Completed 40 enrolled Samik Pharmaceutical Co. Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

The goal of this clinical trial is to evaluate of bioequivalence between fixed-dose combination and co-administration of the individual components under fasting conditions in healthy Korean volunteers.

Timeline

Start
2022-08-30
Primary completion
2022-09-01
Completion
2022-09-21

Drugs

EvaluationDrugModalityDoseRoute
Subject SIPS-2209-1 Unknown — Oral
Subject SIPS-2209-2 Unknown — Oral
Subject SIPS-2209-3 Unknown — Oral

Indications

No indication recorded.